Cargando…
Validation of survival prediction models for ECMO in Sars-CoV-2-related acute respiratory distress syndrome
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210051/ https://www.ncbi.nlm.nih.gov/pubmed/35729619 http://dx.doi.org/10.1186/s13054-022-04039-4 |
_version_ | 1784730073968934912 |
---|---|
author | Moyon, Quentin Pineton de Chambrun, Marc Lebreton, Guillaume Chaieb, Hédi Combes, Alain Schmidt, Matthieu |
author_facet | Moyon, Quentin Pineton de Chambrun, Marc Lebreton, Guillaume Chaieb, Hédi Combes, Alain Schmidt, Matthieu |
author_sort | Moyon, Quentin |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9210051 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92100512022-06-21 Validation of survival prediction models for ECMO in Sars-CoV-2-related acute respiratory distress syndrome Moyon, Quentin Pineton de Chambrun, Marc Lebreton, Guillaume Chaieb, Hédi Combes, Alain Schmidt, Matthieu Crit Care Correspondence BioMed Central 2022-06-21 /pmc/articles/PMC9210051/ /pubmed/35729619 http://dx.doi.org/10.1186/s13054-022-04039-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Correspondence Moyon, Quentin Pineton de Chambrun, Marc Lebreton, Guillaume Chaieb, Hédi Combes, Alain Schmidt, Matthieu Validation of survival prediction models for ECMO in Sars-CoV-2-related acute respiratory distress syndrome |
title | Validation of survival prediction models for ECMO in Sars-CoV-2-related acute respiratory distress syndrome |
title_full | Validation of survival prediction models for ECMO in Sars-CoV-2-related acute respiratory distress syndrome |
title_fullStr | Validation of survival prediction models for ECMO in Sars-CoV-2-related acute respiratory distress syndrome |
title_full_unstemmed | Validation of survival prediction models for ECMO in Sars-CoV-2-related acute respiratory distress syndrome |
title_short | Validation of survival prediction models for ECMO in Sars-CoV-2-related acute respiratory distress syndrome |
title_sort | validation of survival prediction models for ecmo in sars-cov-2-related acute respiratory distress syndrome |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9210051/ https://www.ncbi.nlm.nih.gov/pubmed/35729619 http://dx.doi.org/10.1186/s13054-022-04039-4 |
work_keys_str_mv | AT moyonquentin validationofsurvivalpredictionmodelsforecmoinsarscov2relatedacuterespiratorydistresssyndrome AT pinetondechambrunmarc validationofsurvivalpredictionmodelsforecmoinsarscov2relatedacuterespiratorydistresssyndrome AT lebretonguillaume validationofsurvivalpredictionmodelsforecmoinsarscov2relatedacuterespiratorydistresssyndrome AT chaiebhedi validationofsurvivalpredictionmodelsforecmoinsarscov2relatedacuterespiratorydistresssyndrome AT combesalain validationofsurvivalpredictionmodelsforecmoinsarscov2relatedacuterespiratorydistresssyndrome AT schmidtmatthieu validationofsurvivalpredictionmodelsforecmoinsarscov2relatedacuterespiratorydistresssyndrome |